IntrinsicIntrinsic
← Scroll for more →

Financial Statements — FUSE

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Cash & Equivalents0.371.779.40--
Short-term Investments------12.29
Accounts Receivable1.131.24----
Total Current Assets1.993.74--12.35
Property, Plant & Equipment0.270.29----
Intangible Assets0.230.21----
Total Non-current Assets*0.500.50--0.00
Total Assets3.174.94--12.35
Accounts Payable4.974.68--0.35
Short-term Debt0.120.17----
Total Current Liabilities18.7418.13--43.91
Long-term Debt0.300.30----
Total Non-current Liabilities*1.791.85--0.00
Total Liabilities20.5319.98--43.91
Retained Earnings(38.95)(36.10)--(32.88)
Total Stockholder Equity(17.35)(15.03)--(11.60)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Total Revenue1.791.88----
Cost of Revenue0.830.93----
Gross Profit0.960.95----
Research & Development0.290.30----
Selling, General & Admin2.983.278.090.03
Total Operating Expenses3.653.988.351.13
Operating Income(2.69)(3.03)(4.04)(1.13)
Pretax Income(2.85)(0.87)----
Tax Provision0.000.00----
Net Income(2.85)(0.87)21.18(19.84)
Basic EPS(0.10)(0.03)----
Diluted EPS(0.10)(0.03)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Operating Cash Flow(1.29)(2.22)(5.29)(0.24)
Capital Expenditures0.010.02----
Free Cash Flow*(1.29)(2.24)----
Investing Cash Flow(0.06)(0.06)(3.91)3.74
Financing Cash Flow(0.05)(0.17)13.00(3.58)
← Scroll for more columns →

* Derived from reported values